Literature DB >> 29630107

LINC00963 promotes hepatocellular carcinoma progression by activating PI3K/AKT pathway.

J-H Wu1, X-Y Tian, Q-M An, X-Y Guan, C-Y Hao.   

Abstract

OBJECTIVE: To explore the role of LINC00963 in the pathogenesis of hepatocellular carcinoma and its underlying mechanisms. PATIENTS AND METHODS: The expression level of LINC00963 in 48 cases of hepatocellular carcinoma (HCC) tissues and paracancerous tissues were detected by quantitative Real-time (qRT-PCR). Survival analysis was carried out based on the expression level of LINC00963. The association between the expression level of LINC00963 and clinical characteristics of these subjects was analyzed by x2-test. The proliferation and cell cycle of HCC cells after transfection of LINC00963 overexpression plasmids were evaluated by cell counting kit-8 (CCK-8) assay and flow cytometry, respectively.
RESULTS: The expression level of LINC00963 in HCC tissues was remarkably higher than that in paracancerous tissues, indicating a potential diagnostic significance of LINC00963. The progression-free -with the tumor size and TNM stage, but not with age, gender, histological type and lymph node metastasis. Overexpression of LINC00963 significantly enhanced the proliferation ability of HepG2 and HCC cells and prolonged their G0/G1 phase. Furthermore, the PI3K/AKT expression was increased after overexpression of LINC00963, while AKT siRNA effectively reversed the prolonged G0/G1 phase caused by LINC00963 overexpression.
CONCLUSIONS: Our data revealed that LINC00963 was upregulated in HCC, which significantly extended the G0/G1 phase of HCC cells by activating PI3K/AKT pathway and promoting the proliferative ability of HCC cells. LINC00963 may be involved in the HCC development.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29630107     DOI: 10.26355/eurrev_201803_14574

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  21 in total

1.  Long noncoding RNA LINC00963 promotes breast cancer progression by functioning as a molecular sponge for microRNA-625 and thereby upregulating HMGA1.

Authors:  Zhen Wu; Wei Wang; Yongkun Wang; Xin Wang; Shanping Sun; Yumin Yao; Yang Zhang; Zhongxi Ren
Journal:  Cell Cycle       Date:  2020-02-13       Impact factor: 4.534

2.  Development and Validation of a Novel Ferroptosis-Related LncRNA Signature for Predicting Prognosis and the Immune Landscape Features in Uveal Melanoma.

Authors:  Xiaochen Ma; Sejie Yu; Bin Zhao; Wei Bai; Yubo Cui; Jinglan Ni; Qinghua Lyu; Jun Zhao
Journal:  Front Immunol       Date:  2022-06-14       Impact factor: 8.786

3.  The potential roles of lncRNAs DUXAP8, LINC00963, and FOXD2-AS1 in luminal breast cancer based on expression analysis and bioinformatic approaches.

Authors:  Maedeh Arabpour; Sepideh Mehrpour Layeghi; Javad Tavakkoly Bazzaz; Mohammad Mehdi Naghizadeh; Keivan Majidzadeh-A; Abbas Shakoori
Journal:  Hum Cell       Date:  2021-05-27       Impact factor: 4.174

4.  LINC00963 Functions as an Oncogene in Bladder Cancer by Regulating the miR-766-3p/MTA1 Axis.

Authors:  Ning Zhou; Xiaofei Zhu; Libo Man
Journal:  Cancer Manag Res       Date:  2020-05-12       Impact factor: 3.989

5.  LINC00963 Confers Oncogenic Properties in Glioma by Regulating the miR-506/BCAT1 Axis.

Authors:  Feng Ye; Ronghua Xu; Yuanhong Ge; Yi Zheng; Xiaowei Liu; Pingfu Deng; Xuejun Xu
Journal:  Cancer Manag Res       Date:  2020-03-27       Impact factor: 3.989

6.  LINC00963 Promotes Ovarian Cancer Proliferation, Migration and EMT via the miR-378g /CHI3L1 Axis.

Authors:  Wei Liu; Yu-Jia Yang; Qiang An
Journal:  Cancer Manag Res       Date:  2020-01-21       Impact factor: 3.989

7.  lncRNA LINC00963 downregulation regulates colorectal cancer tumorigenesis and progression via the miR‑10b/FGF13 axis.

Authors:  Yujin Wu; Longling Cong; Wenjian Chen; Xuechuan Wang; Fanghua Qiu
Journal:  Mol Med Rep       Date:  2021-01-26       Impact factor: 2.952

8.  The regulation of miR-320a/XBP1 axis through LINC00963 for endoplasmic reticulum stress and autophagy in diffuse large B-cell lymphoma.

Authors:  Yuying Cui; Hui Xu; Yu Yang; Dongmei Zhao; Yu Wen; Chao Lv; Hongbin Qiu; Chennan Wang
Journal:  Cancer Cell Int       Date:  2021-06-10       Impact factor: 5.722

9.  LncRNA LINC00963 Promotes Tumorigenesis and Radioresistance in Breast Cancer by Sponging miR-324-3p and Inducing ACK1 Expression.

Authors:  Na Zhang; Xue Zeng; Chaonan Sun; Hong Guo; Tianlu Wang; Linlin Wei; Yaotian Zhang; Jiaming Zhao; Xinchi Ma
Journal:  Mol Ther Nucleic Acids       Date:  2019-10-22       Impact factor: 8.886

10.  LINC00963 facilitates acute myeloid leukemia development by modulating miR-608/MMP-15.

Authors:  Wenli Zuo; Keshu Zhou; Mei Deng; Quande Lin; Qingsong Yin; Chunlei Zhang; Jian Zhou; Yongping Song
Journal:  Aging (Albany NY)       Date:  2020-10-04       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.